Cargando…

Easyhaler(®): an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

Inhalation therapy is likely to continue to dominate asthma and chronic obstructive pulmonary disease (COPD) treatment. The pressurised metered-dose inhaler (pMDI) accounts for most of the global inhaler market, but this kind of device is difficult to use properly. Dry powder inhalers (DPIs) have se...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lavorini, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555222/ https://www.ncbi.nlm.nih.gov/pubmed/31210773 http://dx.doi.org/10.7573/dic.212596

Ejemplares similares

Switching to the Dry-Powder Inhaler Easyhaler(®): A Narrative Review of the Evidence
por: Lavorini, Federico, et al.
Publicado: (2021)

Consistent Dosing Through the Salmeterol–Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime
por: Turpeinen, Anni, et al.
Publicado: (2021)

Today’s improvement in asthma treatment: role of MART and Easyhaler
por: Di Marco, Fabiano
Publicado: (2020)

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
por: Price, David, et al.
Publicado: (2014)

Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler(®) dry powder inhaler: a pooled analysis of two randomized controlled trials
por: Malmberg, L. Pekka, et al.
Publicado: (2021)

Inhaler Competence and Patient Satisfaction with Easyhaler(®): Results of Two Real-Life Multicentre Studies in Asthma and COPD
por: Gálffy, Gabriella, et al.
Publicado: (2013)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
por: Çakmaklı, Seçil, et al.
Publicado: (2023)

Preference for Easyhaler(®) Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study
por: Alvarez-Gutiérrez, Francisco Javier, et al.
Publicado: (2021)

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective
por: Chan, Amy H. Y., et al.
Publicado: (2021)

The Nurse Practitioners' Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease
por: Scullion, Jane
Publicado: (2018)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease
por: Kocks, Jan Willem H, et al.
Publicado: (2013)

Clinical effectiveness of the Respimat(®) inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
por: Ram, Felix SF, et al.
Publicado: (2011)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues
por: Roggeri, Alessandro, et al.
Publicado: (2016)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study
por: Ramadan, Wijdan H, et al.
Publicado: (2017)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma
por: Hua, Jian-lan, et al.
Publicado: (2021)

Correct inhalation technique is critical in achieving good asthma control
por: Lavorini, Federico, et al.
Publicado: (2013)

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
por: Dal Negro, Roberto W, et al.
Publicado: (2016)

Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
por: Kirjavainen, Merja, et al.
Publicado: (2018)

Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler)
por: Sandler, Niklas, et al.
Publicado: (2016)

Rome Criteria for Exacerbation of Chronic Obstructive Pulmonary Disease: Not Built in a Day
por: Bhatt, Surya P.
Publicado: (2022)

Improved inhaler handling after repeated inhalation guidance for elderly patients with bronchial asthma and chronic obstructive pulmonary disease
por: Usami, Osamu
Publicado: (2022)

Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care
por: Lindh, Annika, et al.
Publicado: (2019)

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data
por: Müller, Veronika, et al.
Publicado: (2016)

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm
por: Wilkie, Morven, et al.
Publicado: (2015)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
por: Hamadi, Hanadi, et al.
Publicado: (2021)

Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease
por: Feldman, Gregory J, et al.
Publicado: (2018)

Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A., et al.
Publicado: (2023)

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Facchinetti, Fabrizio, et al.
Publicado: (2021)

Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting
por: Yawn, Barbara P, et al.
Publicado: (2012)

Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome
por: Rhee, Chin Kook
Publicado: (2015)

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
por: Alvarado-Gonzalez, Alcibey, et al.
Publicado: (2015)

The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD)
por: Green, Clara E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pc913nq81bte15bio073ecpgdu